Philipp Gödel

4PUBLICATIONS
52CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 18, 2026
Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis.

|Jan 09, 2026
Zamtocabtagene autoleucel in relapsed/refractory B-NHL: 5-year follow-up of a CD20/19 tandem CAR T-cell phase 1 trial.

Hyatt Balke-Want, Philipp Gödel, Christoph Schmid

|Jul 11, 2025
Sequential BCMA CAR T-cell therapy in refractory multiple myeloma.

Tim Richardson, Udo Holtick, Jan-Hendrik Frenking

|Nov 10, 2023
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA.

Jan-Michel Heger, Julia Mattlener, Jessica Schneider

Pageof 1

Frequent Collaborators

2 joint publications

Christoph Scheid

2 joint publications

Michael J Hallek

2 joint publications

Nadine Kutsch

2 joint publications

Bastian von Tresckow